Literature DB >> 16966405

Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Robert K Yu1, Seigo Usuki, Toshio Ariga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966405      PMCID： PMC1698092          DOI： 10.1128/IAI.00967-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  106 in total

1.  A Campylobacter jejuni gene associated with immune-mediated neuropathy.

Authors:  A van Belkum; N van den Braak; P Godschalk; W Ang; B Jacobs; M Gilbert; W Wakarchuk; H Verbrugh; H Endtz
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.

Authors:  R D Hadden; H Karch; H P Hartung; J Zielasek; B Weissbrich; J Schubert; A Weishaupt; D R Cornblath; A V Swan; R A Hughes; K V Toyka
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

3.  DNA diversity of the wla gene cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains.

Authors:  N Misawa; K Kawashima; F Kondo; B M Allos; M J Blaser
Journal:  J Endotoxin Res       Date:  2001

4.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 5.  Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.

Authors:  M M Prendergast; A P Moran
Journal:  J Endotoxin Res       Date:  2000

Review 6.  Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders.

Authors:  T Ariga; T Miyatake; R K Yu
Journal:  J Neurosci Res       Date:  2001-09-01       Impact factor: 4.164

7.  Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?

Authors:  N Yuki; M Koga; K Hirata
Journal:  Acta Neurol Scand       Date:  2000-08       Impact factor: 3.209

8.  Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Authors:  P Guerry; C P Ewing; T E Hickey; M M Prendergast; A P Moran
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.

Authors:  G M O'Hanlon; J J Plomp; M Chakrabarti; I Morrison; E R Wagner; C S Goodyear; X Yin; B D Trapp; J Conner; P C Molenaar; S Stewart; E G Rowan; H J Willison
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

Review 10.  Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.

Authors:  A P Moran; M M Prendergast
Journal:  J Autoimmun       Date:  2001-05       Impact factor: 7.094
View more
  50 in total

1.  Guillain-Barre syndrome presenting with sensory disturbance following a herpes virus infection: a case report.

Authors:  Fotinie Ntziora; Athina Euthimiou; Maria Tektonidou; Anastasios Andreopoulos; Kostas Konstantopoulos
Journal:  J Med Case Rep       Date:  2011-12-04

Review 2.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

3.  Bladder dysfunction and hypertension in children with Guillain-Barre syndrome.

Authors:  Louise Watson; Majid Aziz; Grace Vassallo; Nicholas D Plant; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2014-03-22       Impact factor: 3.714

4.  Sulfoglucuronosyl paragloboside promotes endothelial cell apoptosis in inflammation: elucidation of a novel glycosphingolipid-signaling pathway.

Authors:  Somsankar Dasgupta; Guanghu Wang; Robert K Yu
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

5.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

6.  A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples.

Authors:  Seigo Usuki; Dawn O'Brien; Michael H Rivner; Robert K Yu
Journal:  J Immunol Methods       Date:  2014-05-23       Impact factor: 2.303

7.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis.

Authors:  Angie Rupp; Francesc Galban-Horcajo; Ezio Bianchi; Maurizio Dondi; Jacques Penderis; Joanna Cappell; Karl Burgess; Kaspar Matiasek; Rhona McGonigal; Hugh J Willison
Journal:  J Peripher Nerv Syst       Date:  2013-03       Impact factor: 3.494

9.  Campylobacteriosis in Austria: situation and trends.

Authors:  Gebhard Feierl; Sandra Jelovcan
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.